These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9918050)

  • 21. Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice.
    Gautier T; Masson D; Jong MC; Pais de Barros JP; Duverneuil L; Le Guern N; Deckert V; Dumont L; Bataille A; Zak Z; Jiang XC; Havekes LM; Lagrost L
    Biochem J; 2005 Jan; 385(Pt 1):189-95. PubMed ID: 15339254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of HDL cholesterol concentration with the -629C>A CETP promoter polymorphism is not fully explained by its relationship with plasma cholesteryl ester transfer.
    Dullaart RP; Borggreve SE; Hillege HL; Dallinga-Thie GM
    Scand J Clin Lab Invest; 2008; 68(2):99-105. PubMed ID: 17852818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholesteryl ester transfer protein directly mediates selective uptake of high density lipoprotein cholesteryl esters by the liver.
    Gauthier A; Lau P; Zha X; Milne R; McPherson R
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2177-84. PubMed ID: 16123327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased cholesteryl ester transfer protein activity in impaired glucose tolerance: relationship to high density lipoprotein metabolism.
    Pietzsch J; Fuecker K
    Croat Med J; 2003 Apr; 44(2):171-7. PubMed ID: 12698508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study.
    Frisdal E; Klerkx AH; Le Goff W; Tanck MW; Lagarde JP; Jukema JW; Kastelein JJ; Chapman MJ; Guerin M
    Hum Mol Genet; 2005 Sep; 14(18):2607-18. PubMed ID: 16049032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of a simple picomolar inhibitor of cholesteryl ester transfer protein.
    Reinhard EJ; Wang JL; Durley RC; Fobian YM; Grapperhaus ML; Hickory BS; Massa MA; Norton MB; Promo MA; Tollefson MB; Vernier WF; Connolly DT; Witherbee BJ; Melton MA; Regina KJ; Smith ME; Sikorski JA
    J Med Chem; 2003 May; 46(11):2152-68. PubMed ID: 12747787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma lipoprotein phenotype in response to cholesteryl ester transfer protein levels in dyslipoproteinemia.
    Marcel YL; Tall AR; Hogue M; Milne RW; McPherson R
    Adv Exp Med Biol; 1991; 285():77-80. PubMed ID: 1858579
    [No Abstract]   [Full Text] [Related]  

  • 28. Fluorescent determination of cholesteryl ester transfer protein (CETP) activity in plasma.
    Dousset N; Douste-Blazy L
    Clin Chem; 1992 Feb; 38(2):306. PubMed ID: 1541018
    [No Abstract]   [Full Text] [Related]  

  • 29. Discovery of chiral N,N-disubstituted trifluoro-3-amino-2-propanols as potent inhibitors of cholesteryl ester transfer protein.
    Durley RC; Grapperhaus ML; Massa MA; Mischke DA; Parnas BL; Fobian YM; Rath NP; Honda DD; Zeng M; Connolly DT; Heuvelman DM; Witherbee BJ; Glenn KC; Krul ES; Smith ME; Sikorski JA
    J Med Chem; 2000 Nov; 43(24):4575-8. PubMed ID: 11101348
    [No Abstract]   [Full Text] [Related]  

  • 30. A polymorphism of the gene coding for cholesterol ester transfer protein (CETP) that affects transfer of plasma cholesterol ester and its sensitivity to regulation.
    Girard-Globa A
    Biomed Pharmacother; 1997; 51(9):404-5. PubMed ID: 9452791
    [No Abstract]   [Full Text] [Related]  

  • 31. Fluorescent labeling of lipoproteins.
    Via DP; Smith LC
    Methods Enzymol; 1986; 129():848-57. PubMed ID: 3724556
    [No Abstract]   [Full Text] [Related]  

  • 32. The Yin and Yang of cholesteryl ester transfer protein and atherosclerosis.
    Watts GF
    Clin Sci (Lond); 2002 Dec; 103(6):595-7. PubMed ID: 12444912
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma cholesteryl ester transfer protein.
    Tall AR
    J Lipid Res; 1993 Aug; 34(8):1255-74. PubMed ID: 8409761
    [No Abstract]   [Full Text] [Related]  

  • 34. The binding protein's binding protein--clinical applications of acid-labile subunit (ALS) measurement.
    Baxter RC
    J Clin Endocrinol Metab; 1997 Dec; 82(12):3941-3. PubMed ID: 9398692
    [No Abstract]   [Full Text] [Related]  

  • 35. Positive Association between Autoantibodies Against Oxidized LDL and HDL-C: A Novel Mechanism for HDL Cardioprotection?
    Nunez CEC; Oliveira JB; Barros-Mazon S; Zago VHS; Kaplan DB; Nakamura RT; Gidlund MA; Gomes EIL; Cazita PM; Nakandakare E; Carmo HR; Sposito AC; Faria EC
    Arq Bras Cardiol; 2022 Sep; 119(5):714-21. PubMed ID: 36074481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of SNVs in ABCA1, ABCG1, ABCG5, ABCG8, and SCARB1 Genes on Plasma Lipids, Lipoproteins, and Adiposity Markers in a Brazilian Population.
    Zago VHS; Scherrer DZ; Parra ES; Vieira IC; Marson FAL; de Faria EC
    Biochem Genet; 2022 Apr; 60(2):822-841. PubMed ID: 34505223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mathematical model to estimate cholesterylester transfer protein (CETP) triglycerides flux in human plasma.
    Jansen M; Puetz G; Hoffmann MM; Winkler K
    BMC Syst Biol; 2019 Jan; 13(1):12. PubMed ID: 30670016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p.Q192R SNP of PON1 seems not to be Associated with Carotid Atherosclerosis Risk Factors in an Asymptomatic and Normolipidemic Brazilian Population Sample.
    Scherrer DZ; Zago VH; Vieira IC; Parra ES; Panzoldo NB; Alexandre F; Secolin R; Baracat J; Quintão EC; Faria EC
    Arq Bras Cardiol; 2015 Jul; 105(1):45-52. PubMed ID: 26039660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HDL size is more accurate than HDL cholesterol to predict carotid subclinical atherosclerosis in individuals classified as low cardiovascular risk.
    Parra ES; Panzoldo NB; Zago VH; Scherrer DZ; Alexandre F; Bakkarat J; Nunes VS; Nakandakare ER; Quintão EC; Nadruz W; de Faria EC; Sposito AC
    PLoS One; 2014; 9(12):e114212. PubMed ID: 25470778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between ABCG1 polymorphism rs1893590 and high-density lipoprotein (HDL) in an asymptomatic Brazilian population.
    Zago VH; Scherrer DZ; Parra ES; Panzoldo NB; Alexandre F; Nakandakare ER; Quintão EC; de Faria EC
    Mol Biol Rep; 2015 Mar; 42(3):745-54. PubMed ID: 25398214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.